Starpharma Holdings

What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%



Code Company Date Close Change Indicator Value Signal

Trading Performance

Triangular Moving Average



Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 22 13.7 0.23% 0.29% 9.4% -3.6% -14.6%
SHORT 22 21.3 0.27% 0.35% 12.0% -3.8% 6.6%


Technical Analysis

Starpharma Holdings (SPL.AX)



Last Signal:


Trading: SELL @ $1.19
Signal Strength: STRONG

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to highlight trends across numerous timeframes. This indicator has the ability to smooth historical results to illustrate trend initiation and status. Although this is a simple trend following indicator & can provide good results when coupled with the right indicator. Note, this indicator does not work well in ranging markets producing unwanted whipsaws and false signals.

Starpharma Holdings (ASX:SPL) currently has a confirmed downtrend. Recent trading has caused the TMA 15 day average to move below the closing price confirming the short term trend following indicator. Currently, the return on TMA15 is -0.4%.

A triangular moving average can be calculated using various input data such as prices volume or another technical indicator.

Calculation: Triangular Moving Average (TMA):
1) SMA: n period sum / n;
2) TMA = (n SMA period sum) / N;

PROFILE: Starpharma Holdings (SPL.AX)

Stock Exchange: ASX
Company: Starpharma Holdings
Ticker Codes: | SPL.AX | ASX:SPL |

About Starpharma Holdings (ASX:SPL):

Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications primarily in Australia and Canada. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections. It also develops dendrimer-enhanced, or DEP versions of existing drugs, including DEP docetaxel that is in Phase I clinical trial for breast, prostate, lung, and ovarian tumor. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

Top 10:

Triangular Moving Average

Company Close Change(%) Volume Value Signal
FBR Fastbrick Robotics 0.06 5.8 881,024 -6 BEARISH
NZK New Zealand King Salmon Investments 2.2 5.3 8,766 -12.8 BEARISH
HUO Huon Aquaculture 4.7 4.4 14,880 -0.2 BEARISH
VRL Village Roadshow 4.02 4.4 636,398 -16.3 BEARISH
CAT Catuity 2.17 3.8 509,665 -0.6 BEARISH
VRT Virtus Health 4.47 3.2 173,410 -1.8 BEARISH
VGL Volante 3.64 3.1 46,740 -10.5 BEARISH
MDC Mcconnell Dowell Corporation 0.35 3 134,368 -3.1 BEARISH
PPH Pan Pharmaceuticals 4.4 2.6 25,572 -1.3 BEARISH
SOM Somnomed 2.91 2.5 8,890 -1.4 BEARISH